Kan Kaneko
Liverpool, ENG L33AF, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Pneumococcal Surface Protein A-Hybrid Nanoparticles Protect Mice from Lethal Challenge after Mucosal Immunization Targeting the Lungs.
Journal: Pharmaceutics
Published: April 29, 2022
In Vitro Characterization of Inhalable Cationic Hybrid Nanoparticles as Potential Vaccine Carriers.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 06, 2021
Evaluation of polymer choice on immunogenicity of chitosan coated PLGA NPs with surface-adsorbed pneumococcal protein antigen PspA4Pro.
Journal: International journal of pharmaceutics
Published: January 05, 2021
An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery.
Journal: Pharmaceutics
Published: December 30, 2020
Progress in mucosal immunization for protection against pneumococcal pneumonia.
Journal: Expert review of vaccines
Published: July 16, 2019
Carriers for the targeted delivery of aerosolized macromolecules for pulmonary pathologies.
Journal: Expert opinion on drug delivery
Published: July 19, 2018
Characterization and evaluation of stabilized particulate formulations as therapeutic oral vaccines for allergy.
Journal: Journal of liposome research
Published: August 23, 2017
Liposomal α-galactosylceramide is taken up by gut-associated lymphoid tissue and stimulates local and systemic immune responses.
Journal: The Journal of pharmacy and pharmacology
Published: June 14, 2017
Vaccination of Sheep with a Methanogen Protein Provides Insight into Levels of Antibody in Saliva Needed to Target Ruminal Methanogens.
Journal: PloS one
Published: February 24, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026